Do You Actually Need Allergy Immunotherapy? A Self-Assessment

Quick Answer

Allergy immunotherapy is indicated when you have demonstrated IgE-mediated allergies and inadequate control on standard medications — or when you want to stop taking daily meds altogether. According to AAAAI/ACAAI guidelines, candidates include those with medication side effects, comorbid asthma, or a desire to avoid long-term pharmacotherapy. Despite 82 million Americans having allergic rhinitis (2024 NHIS), only 4.4% of eligible patients receive immunotherapy (MarketScan data; Pfaar 2023 WAO).

Quick Facts

Detail	Info
Americans with allergic rhinitis	82 million — 25.2% adults, 20.6% children (2024 NHIS)
Moderate-severe candidates	~12–24 million Americans
Patients who actually receive AIT	4.4% (MarketScan); 85–95% of eligible never treated
No relief from any medications	14% of AR patients (Meltzer 2012)
AR-to-asthma risk multiplier	3.8× (OR)
Annual cost comparison	Generic cetirizine = $10.49/year; allergy drops = $39–99/month for 3–5 years (2026)

"Am I Bad Enough to Need Immunotherapy?"

You refill your cetirizine prescription like clockwork, add a nasal spray in March, and stack on eye drops by April. Six months a year, you wake up with a throat full of drainage and eyes that look like you cried through the night. You function — technically — but "functioning" means a permanent fog of fatigue that no amount of coffee clears.

Then your allergist mentions immunotherapy and you freeze. It sounds serious. Expensive. Time-consuming. You wonder if you're overreacting — plenty of people have allergies and just deal with it.

Why This Happens — The Medication Ceiling

Step 1 — Antihistamines only block one pathway. Cetirizine, loratadine, and fexofenadine target histamine H1 receptors, but allergic inflammation involves leukotrienes, prostaglandins, and dozens of other mediators. When your body mounts a full IgE response, blocking one receptor type leaves the rest unchecked (Bousquet 2020 ARIA update).

Step 2 — Combination therapy has a defined ceiling. The step-up threshold in current guidelines: intranasal corticosteroid plus intranasal antihistamine combo (e.g., Dymista) for 2–4 weeks. If symptoms remain moderate-severe after that trial, you've reached the pharmacotherapy ceiling. At that point, guidelines specifically recommend considering immunotherapy (AAAAI/ACAAI 2017 Joint Practice Parameter).

Step 3 — Untreated moderate-severe AR escalates. Patients with persistent moderate-severe allergic rhinitis have a 3.8× increased risk of developing asthma. The 14% who report zero relief from medications (Meltzer 2012) aren't imagining it — they've genuinely exhausted what symptom-blockers can do.

What To Do Next

Step 1 — Score your symptom burden (free). Count your bad-allergy months per year and daily medications. If you have 3+ months of symptoms per year AND/OR take 2+ daily allergy medications, you cross the threshold where immunotherapy becomes financially and medically rational. Track one week using a simple 0–10 daily severity score.

Step 2 — Confirm with objective testing. Allergy testing (skin prick or specific IgE blood test) confirms whether your symptoms are IgE-mediated. This matters because immunotherapy only works on IgE-driven allergies, not non-allergic rhinitis (which affects ~25% of rhinitis patients). Home allergy tests cost $79–249 and identify your specific triggers.

Step 3 — Take the allergy quiz to see your options. A 3-minute assessment identifies your triggers, symptom severity, and whether you're likely a candidate for drops, shots, or continued medication management.

Take the free 3-minute allergy quiz →

When Immunotherapy Isn't Worth It

If your allergies are mild, last fewer than 3 months per year, and respond well to a single generic antihistamine at $10.49/year — immunotherapy at $39–99/month for 3–5 years doesn't make financial sense. That math changes if: you take 2+ daily medications ($300–800/year combined), miss work or school due to symptoms, have worsening seasonal asthma, or experience medication side effects like drowsiness or rebound congestion.

Immunotherapy also isn't appropriate if you have severe uncontrolled asthma (FEV1 < 70% predicted), are on high-dose beta-blockers without alternatives, or have an immunodeficiency that prevents immune modulation. These are relative contraindications — discuss specifics with your provider.

Related Issues to Check

• Allergy drops vs. allergy shots — If you decide immunotherapy is right, understanding the efficacy, safety, and cost differences between SLIT and SCIT determines which format fits your life.

• Antihistamines stopped working — what now? — If medication failure is what brought you here, this guide explains the pharmacological reasons behind tolerance and what evidence supports as next steps.

• Allergy drops cost per month — The financial comparison between ongoing medication costs and a defined immunotherapy course helps you make the cost-benefit calculation with real numbers.

Frequently Asked Questions

How do I know if my allergies are "bad enough" for immunotherapy? If you have 3+ months of symptoms per year, take 2+ daily medications, or have allergy-triggered asthma, you meet standard candidacy criteria (AAAAI/ACAAI guidelines). Severity is measured by impact on sleep, work, and daily function — not by your perception of whether others have it worse.

Can I just keep taking antihistamines forever? You can, and for mild allergies that's reasonable. But antihistamines don't modify disease — they suppress symptoms while you take them. Immunotherapy is the only treatment that changes your underlying immune response and can produce lasting remission after 3–5 years.

Why hasn't my doctor mentioned immunotherapy? Only 4.4% of eligible patients receive immunotherapy. Many primary care providers don't prescribe it, and allergist referral wait times average 3–8 weeks. The treatment is underutilized, not inappropriate.

Is it worth the cost if generic Zyrtec is $10/year? Generic cetirizine costs $10.49/year, but most moderate-severe patients take multiple medications. Factor in nasal sprays ($120–240/year), eye drops ($60–180/year), and missed productivity. Immunotherapy at $39–99/month for 3–5 years produces lasting benefit that medications cannot.

What if I only have allergies one season? Single-season allergies (e.g., ragweed only) can be treated with pre-seasonal SLIT protocols. The cost-benefit is less clear than for year-round sufferers, but the 3.8× asthma risk still applies to seasonal patients with moderate-severe symptoms.

Do I need a formal allergy test first? Yes. Immunotherapy requires confirmed IgE-mediated allergy via skin prick or blood test. Treating without confirmation risks treating non-allergic rhinitis, which won't respond to immunotherapy.

Last reviewed: March 2026 · Sources verified against current data

Medically reviewed by Dr. Chet Tharpe, MD · March 2026

Take the Next Step

Not sure where you fall? A 3-minute quiz matches your symptom pattern and medication history against candidacy criteria — no cost, no commitment.

Take the free 3-minute allergy quiz →